Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail
- PMID: 12914917
- DOI: 10.1016/s0014-5793(03)00748-8
Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail
Abstract
Anomalous expansion of a polyglutamine (polyQ) tract in the protein ataxin-3 causes spinocerebellar ataxia type 3, an autosomal dominant neurodegenerative disease. Very little is known about the structure and the function of ataxin-3, although this information would undoubtedly help to understand why the expanded protein forms insoluble nuclear aggregates and causes neuronal cell death. With the aim of establishing the domain architecture of ataxin-3 and the role of the polyQ tract within the protein context, we have studied the human and murine orthologues using a combination of techniques, which range from limited proteolysis to circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopies. The two protein sequences share a highly conserved N-terminus and differ only in the length of the glutamine repeats and in the C-terminus. Our data conclusively indicate that ataxin-3 is composed by a structured N-terminal domain, followed by a flexible tail. Moreover, [(15)N]glutamine selectively labelled samples allowed us to have a direct insight by NMR into the structure of the polyQ region.
Similar articles
-
Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.J Mol Biol. 2004 Dec 3;344(4):1021-35. doi: 10.1016/j.jmb.2004.09.065. J Mol Biol. 2004. PMID: 15544810
-
Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.Protein Sci. 2011 Oct;20(10):1675-81. doi: 10.1002/pro.698. Epub 2011 Aug 18. Protein Sci. 2011. PMID: 21780213 Free PMC article.
-
Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.J Neurochem. 2004 May;89(4):908-18. doi: 10.1111/j.1471-4159.2004.02369.x. J Neurochem. 2004. PMID: 15140190
-
Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.Prog Neurobiol. 2011 Sep 15;95(1):26-48. doi: 10.1016/j.pneurobio.2011.06.007. Epub 2011 Jun 28. Prog Neurobiol. 2011. PMID: 21740957 Review.
-
Progress in pathogenesis studies of spinocerebellar ataxia type 1.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434309 Free PMC article. Review.
Cited by
-
The Toxic Effects of Pathogenic Ataxin-3 Variants in a Yeast Cellular Model.PLoS One. 2015 Jun 8;10(6):e0129727. doi: 10.1371/journal.pone.0129727. eCollection 2015. PLoS One. 2015. PMID: 26052945 Free PMC article.
-
Enhanced molecular mobility of ordinarily structured regions drives polyglutamine disease.J Biol Chem. 2015 Oct 2;290(40):24190-200. doi: 10.1074/jbc.M115.659532. Epub 2015 Aug 10. J Biol Chem. 2015. PMID: 26260925 Free PMC article.
-
Ubiquitin-modifying enzymes in Huntington's disease.Front Mol Biosci. 2023 Feb 8;10:1107323. doi: 10.3389/fmolb.2023.1107323. eCollection 2023. Front Mol Biosci. 2023. PMID: 36926679 Free PMC article. Review.
-
Nucleocytoplasmic shuttling activity of ataxin-3.PLoS One. 2009 Jun 8;4(6):e5834. doi: 10.1371/journal.pone.0005834. PLoS One. 2009. PMID: 19503814 Free PMC article.
-
Machado-Joseph disease/spinocerebellar ataxia type 3.Handb Clin Neurol. 2012;103:437-49. doi: 10.1016/B978-0-444-51892-7.00027-9. Handb Clin Neurol. 2012. PMID: 21827905 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources